These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23617747)

  • 1. Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis.
    Wang J; Zhao H; Tang D; Wu J; Yao G; Zhang Q
    Cancer Biother Radiopharm; 2013 May; 28(4):283-8. PubMed ID: 23617747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.
    Tuomarila M; Luostari K; Soini Y; Kataja V; Kosma VM; Mannermaa A
    PLoS One; 2014; 9(10):e109508. PubMed ID: 25329395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-888 and
    Sedaghati Burkhani S; Salimi M
    Genet Test Mol Biomarkers; 2022 Apr; 26(4):184-190. PubMed ID: 35442769
    [No Abstract]   [Full Text] [Related]  

  • 4. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
    Kopp F; Oak PS; Wagner E; Roidl A
    PLoS One; 2012; 7(11):e50469. PubMed ID: 23209748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Photodynamic Therapy with Subsequent Surgical Treatment of Experimental Breast Cancer on Quantitative Changes in miRNAs in a Mesenteric Lymph Node.
    Kabakov AV; Kazakov OV; Poveshchenko AF; Cherkas VN; Kononchuk VV
    Bull Exp Biol Med; 2024 Jun; 177(2):271-273. PubMed ID: 39090464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Chemotherapy on the Relationship between MicroRNA Levels in the Lymph with Thymus Structure in Experimental Breast Cancer.
    Kazakov OV; Poveshchenko AF; Kabakov AV
    Bull Exp Biol Med; 2023 Sep; 175(5):681-684. PubMed ID: 37861905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Changes in Pro-Oncogenic and Tumor-Suppressing MicroRNA in the Regional Lymph Node during Photodynamic Therapy of Experimental Breast Cancer.
    Kabakov AV; Kazakov OV; Poveshchenko AF; Cherkas VN
    Bull Exp Biol Med; 2024 Feb; 176(4):491-494. PubMed ID: 38492110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Fragmented Human DNA on the Relationship between MicroRNA (miR-21, -221, -222, and -429) of the Lymph and the Structure of the Thymus after Surgical Treatment and Chemotherapy for Breast Cancer.
    Kazakov OV; Kabakov AV; Cherkas VN; Poveshchenko AF
    Bull Exp Biol Med; 2024 Jun; 177(2):261-265. PubMed ID: 39093474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-9 as a paradoxical but critical regulator of cancer metastasis: Implications in personalized medicine.
    Liu Y; Zhao Q; Xi T; Zheng L; Li X
    Genes Dis; 2021 Nov; 8(6):759-768. PubMed ID: 34522706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers.
    Karmakar M; Lai PC; Sinha S; Glaser S; Chakraborty S
    Oncotarget; 2021 Jul; 12(15):1499-1519. PubMed ID: 34316330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment.
    Kudela E; Samec M; Koklesova L; Liskova A; Kubatka P; Kozubik E; Rokos T; Pribulova T; Gabonova E; Smolar M; Biringer K
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2.
    Pan Q; Sun L; Zheng D; Li N; Shi H; Song J; Shao G; Xu G
    Biomed Res Int; 2018; 2018():1769040. PubMed ID: 30175116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in regulation of triple-negative breast cancer progression.
    Piasecka D; Braun M; Kordek R; Sadej R; Romanska H
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1401-1411. PubMed ID: 29923083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides.
    Lima JF; Carvalho J; Pinto-Ribeiro I; Almeida C; Wengel J; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    BMC Mol Biol; 2018 Jun; 19(1):6. PubMed ID: 29879907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.
    Baldassari F; Zerbinati C; Galasso M; Corrà F; Minotti L; Agnoletto C; Previati M; Croce CM; Volinia S
    Front Genet; 2018; 9():174. PubMed ID: 29868122
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-miRNA oligonucleotides: A comprehensive guide for design.
    Lima JF; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    RNA Biol; 2018 Mar; 15(3):338-352. PubMed ID: 29570036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2.
    Xue F; Liang Y; Li Z; Liu Y; Zhang H; Wen Y; Yan L; Tang Q; Xiao E; Zhang D
    Oncol Lett; 2018 Jan; 15(1):813-820. PubMed ID: 29399149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
    Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH
    Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.
    Deshmukh SK; Srivastava SK; Tyagi N; Ahmad A; Singh AP; Ghadhban AAL; Dyess DL; Carter JE; Dugger K; Singh S
    Carcinogenesis; 2017 Aug; 38(8):757-765. PubMed ID: 28430867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
    Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
    Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.